Ajanta Pharma Limited (NSE:AJANTPHARM)
India flag India · Delayed Price · Currency is INR
2,585.20
-120.90 (-4.47%)
May 2, 2025, 3:29 PM IST

Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 322.86 billion. The enterprise value is 317.18 billion.

Market Cap 322.86B
Enterprise Value 317.18B

Important Dates

The last earnings date was Friday, May 2, 2025.

Earnings Date May 2, 2025
Ex-Dividend Date Nov 6, 2024

Share Statistics

Ajanta Pharma has 124.89 million shares outstanding. The number of shares has decreased by -0.66% in one year.

Current Share Class n/a
Shares Outstanding 124.89M
Shares Change (YoY) -0.66%
Shares Change (QoQ) -0.32%
Owned by Insiders (%) 42.33%
Owned by Institutions (%) 19.93%
Float 41.84M

Valuation Ratios

The trailing PE ratio is 35.16 and the forward PE ratio is 30.69. Ajanta Pharma's PEG ratio is 2.74.

PE Ratio 35.16
Forward PE 30.69
PS Ratio 6.95
PB Ratio 8.52
P/TBV Ratio 8.62
P/FCF Ratio 38.47
P/OCF Ratio 27.90
PEG Ratio 2.74
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.01, with an EV/FCF ratio of 37.79.

EV / Earnings 34.46
EV / Sales 6.82
EV / EBITDA 25.01
EV / EBIT 28.21
EV / FCF 37.79

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.01.

Current Ratio 2.85
Quick Ratio 1.80
Debt / Equity 0.01
Debt / EBITDA 0.04
Debt / FCF 0.06
Interest Coverage 54.23

Financial Efficiency

Return on equity (ROE) is 25.02% and return on invested capital (ROIC) is 18.88%.

Return on Equity (ROE) 25.02%
Return on Assets (ROA) 14.56%
Return on Invested Capital (ROIC) 18.88%
Return on Capital Employed (ROCE) 27.97%
Revenue Per Employee 5.76M
Profits Per Employee 1.14M
Employee Count 8,073
Asset Turnover 0.96
Inventory Turnover 1.24

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +16.69% in the last 52 weeks. The beta is 0.22, so Ajanta Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.22
52-Week Price Change +16.69%
50-Day Moving Average 2,613.43
200-Day Moving Average 2,859.67
Relative Strength Index (RSI) 45.64
Average Volume (20 Days) 97,373

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 46.48 billion and earned 9.20 billion in profits. Earnings per share was 73.53.

Revenue 46.48B
Gross Profit 35.77B
Operating Income 11.24B
Pretax Income 11.89B
Net Income 9.20B
EBITDA 12.68B
EBIT 11.24B
Earnings Per Share (EPS) 73.53
Full Income Statement

Balance Sheet

The company has 6.15 billion in cash and 474.20 million in debt, giving a net cash position of 5.68 billion or 45.44 per share.

Cash & Cash Equivalents 6.15B
Total Debt 474.20M
Net Cash 5.68B
Net Cash Per Share 45.44
Equity (Book Value) 37.90B
Book Value Per Share 303.53
Working Capital 18.47B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.57 billion and capital expenditures -3.18 billion, giving a free cash flow of 8.39 billion.

Operating Cash Flow 11.57B
Capital Expenditures -3.18B
Free Cash Flow 8.39B
FCF Per Share 67.21
Full Cash Flow Statement

Margins

Gross margin is 76.96%, with operating and profit margins of 24.19% and 19.80%.

Gross Margin 76.96%
Operating Margin 24.19%
Pretax Margin 25.58%
Profit Margin 19.80%
EBITDA Margin 27.29%
EBIT Margin 24.19%
FCF Margin 18.06%

Dividends & Yields

This stock pays an annual dividend of 56.00, which amounts to a dividend yield of 2.17%.

Dividend Per Share 56.00
Dividend Yield 2.17%
Dividend Growth (YoY) n/a
Years of Dividend Growth 3
Payout Ratio 37.96%
Buyback Yield 0.66%
Shareholder Yield 2.83%
Earnings Yield 2.85%
FCF Yield 2.60%
Dividend Details

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date Jun 22, 2022
Split Type Forward
Split Ratio 1.5

Scores

Altman Z-Score n/a
Piotroski F-Score n/a